Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Dorian LPG
LPG
$1.95B
| $1.42M | ﹤0.01% |
58,515
+5,302
| +10% | +$139K |
|
3152
CALL
Agios Pharmaceuticals
AGIO
$2B
| $1.42M | ﹤0.01% |
+52,200
| New | +$1.83M |
|
3153
PUT
Workday
WDAY
$51B
| $1.42M | ﹤0.01% |
6,600
-490,000
| -99% | -$111M |
|
3154
PUT
NuScale Power
SMR
$4.04B
| $1.42M | ﹤0.01% |
+100,000
| New | +$2.86M |
|
3155
AXT Inc
AXTI
$5.07B
| $1.42M | ﹤0.01% |
+86,582
| New | +$836K |
|
3156
CALL
WillScot Mobile Mini Holdings
WSC
$4.17B
| $1.41M | ﹤0.01% |
+75,000
| New | +$1.51M |
|
3157
Hingham Institution for Saving
HIFS
$686M
| $1.41M | ﹤0.01% |
4,969
+2,226
| +81% | +$636K |
|
3158
Navient
NAVI
$867M
| $1.41M | ﹤0.01% |
108,361
-70,066
| -39% | -$872K |
|
3159
Phathom Pharmaceuticals
PHAT
$743M
| $1.41M | ﹤0.01% |
84,859
-43,497
| -34% | -$621K |
|
3160
CALL
National Grid
NGG
$81.6B
| $1.41M | ﹤0.01% |
+18,200
| New | +$1.37M |
|
3161
SunCoke Energy
SXC
$788M
| $1.4M | ﹤0.01% |
195,071
+35,232
| +22% | +$259K |
|
3162
NB Bancorp
NBBK
$1B
| $1.4M | ﹤0.01% |
70,772
+17,894
| +34% | +$340K |
|
3163
Eagle Bancorp
EGBN
$877M
| $1.4M | ﹤0.01% |
65,458
+19,349
| +42% | +$373K |
|
3164
Alight
ALIT
$394M
| $1.4M | ﹤0.01% |
35,910
+2,200
| +7% | +$110K |
|
3165
Central Garden & Pet Co
CENT
$2.78B
| $1.4M | ﹤0.01% |
43,520
+411
| +1% | +$13.1K |
|
3166
Nature's Sunshine
NATR
$269M
| $1.39M | ﹤0.01% |
64,609
+2,310
| +4% | +$42.4K |
|
3167
CVR Energy
CVI
$3.58B
| $1.39M | ﹤0.01% |
54,747
-3,669
| -6% | -$125K |
|
|
ALH
3168
Alliance Laundry Holdings
ALH
$5.12B
| $1.39M | ﹤0.01% |
+68,397
| New | +$1.64M |
|
|
TE
3169
T1 Energy
TE
$1.41B
| $1.39M | ﹤0.01% |
208,273
+51,002
| +32% | +$225K |
|
3170
LendingTree
TREE
$461M
| $1.38M | ﹤0.01% |
26,025
+7,395
| +40% | +$415K |
|
|
3171
WillScot Mobile Mini Holdings
WSC
$4.17B
| $1.38M | ﹤0.01% |
73,300
-53,352
| -42% | -$1.08M |
|
3172
FMC
FMC
$1.27B
| $1.38M | ﹤0.01% |
99,491
-14,896
| -13% | -$284K |
|
3173
Grid Dynamics Holdings
GDYN
$644M
| $1.38M | ﹤0.01% |
152,701
-5,615
| -4% | -$48.6K |
|
3174
CALL
BioMarin Pharmaceuticals
BMRN
$13.3B
| $1.38M | ﹤0.01% |
+23,200
| New | +$1.26M |
|
|
3175
PUT
BioMarin Pharmaceuticals
BMRN
$13.3B
| $1.38M | ﹤0.01% |
+23,200
| New | +$1.26M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.